- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07605585
Sensory Neurography and S2PD, a Test-Retest Study
Sensory Neurography and S2PD: A Test-Retest Study in Ten Healthy Individuals to Assess Method Reliability
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A neurophysiological examination can objectively measure remaining function in an injured digital nerve. Using this method, axons that are still able to conduct an action potential are assessed.
The response can be measured as the amplitude (the summed action potentials from the nerve's axons) and as the area (the amount of functioning axons). The area is a somewhat more precise measurement method, as it includes all axons, both those with low and high conduction velocities. Amplitude measurements may give falsely low values if nerves with poorer degrees of myelination are included in the measurement. Amplitude is measured in µV (microvolt) and area in µV/ms (microvolt per millisecond).
The method currently used to assess discriminative sensation is the S2PD-test. In this test two pins are pressed perpendicular and longitudinally on each side of the fingertip. The pins can consist of an unfolded paper clip or a factory-made discriminator. The distance between the two pins, where it is possible to discriminate between one or two pins, is the S2PD. The test is influenced by many external factors, such as the clinician's level of experience, the patient's desire to give the correct answer, language barriers, and similar issues. Furthermore, this examination method does not clarify what is actually being measured beyond the patient's subjective discriminative sensation.
If neurophysiological assessment is used as a complement to S2PD and can provide an objective measurement tool with high reliability and reproducibility, it could become an important addition to the clinical arsenal for follow-up after nerve injury. Such knowledge would make it easier to clinically evaluate, understand, and monitor the healing process of the injured nerve. It would also facilitate the assessment and systematic follow-up of treatment outcomes.
The participants will be examined at the Hand Surgery Clinic at South General Hospital at two separate occasions separated. Each visit is estimated to last approximately 60 minutes. It will include assessment using S2PD and neurophysiological examination of the radial side of the second and fourth fingers on both hands.
Finger temperature will be measured using an infrared thermometer (Testo 826-T2), and, if necessary, the fingers will be warmed (using a water bath, heating pad or something similar) to a target temperature of a minimum of 32 °C. The hands will then be gently abraded using a preparation gel (NuPrep). Conductive gel (Ten20) will be applied to the electrodes.
A recording electrode will be placed volarly over the wrist, a ground electrode in the palm, and the stimulating electrode on the radial side of the finger (digits II and IV). Electrical stimulation will be delivered in an orthodromic direction, from the finger toward the wrist. The stimulus intensity will be gradually increased until no further increase in amplitude is observed/amplitude is stable. At the first visit, the examination begins with S2PD followed by sensory neurography. At the second visit, the order of the assessments is reversed to minimize potential crossover effects.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden
- Department of Hand Surgery, Södersjukhuset Hospital, Stockholm, Sweden
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age >20
- Age <60
Exclusion Criteria:
- Neurologic disease
- Dementia
- Cognitive disability
- Severe psychiatric disorder (not be able to participate)
- Ongoing drug abuse
- Not understanding swedish language
- History of carpal tunnel syndrome
- Negative experience of electric stimulation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: S2PD and sensory neurography
Radial digital nerve of second and fourth finger on both hands, are first examined with S2PD, secondly with Sensory neurography.
|
see section "study description"
see section "study description"
|
|
Active Comparator: Sensory neurography and S2PD
Radial digital nerve of second and fourth finger on both hands, are first examined with Sensory neurography, secondly with S2PD
|
see section "study description"
see section "study description"
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reliability of method: Sensory neurography measurements (AREA) performed on two separate occasions.
Time Frame: Measures will be assessed at baseline and 2 weeks.
|
ICC (Intraclass correlation coefficient) will be used to assess correlation between measurements at baseline and 2 weeks
|
Measures will be assessed at baseline and 2 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of agreement AREA
Time Frame: Measurements will be performed at baseline and at 2 weeks.
|
The Bland-Altman method will be used to assess whether the measurement method demonstrates sufficient agreement to be considered reliable.
The predefined limit for acceptable differences between measurements is 50%.
|
Measurements will be performed at baseline and at 2 weeks.
|
|
Reliability of method: Sensory neurography measurements (SNAP) performed on two separate occasions
Time Frame: Measures will be assessed at baseline and 2 weeks.
|
ICC (Intraclass correlation coefficient) will be used to assess whether the measurement method demonstrates sufficient correlation to be considered reliable.
|
Measures will be assessed at baseline and 2 weeks.
|
|
Assessment of agreement SNAP
Time Frame: Measurements at baseline and 2 weeks
|
The Bland-Altman method will be used to assess whether the measurement method demonstrates sufficient agreement to be considered reliable.
The predefined limit for acceptable differences between measurements is 50%.
|
Measurements at baseline and 2 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cecilia Mellstrand Navarrro, Associate professor, Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden
Publications and helpful links
General Publications
- Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 Feb 8;1(8476):307-10.
- Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999 Jun;8(2):135-60. doi: 10.1177/096228029900800204.
- Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet. 1995 Oct 21;346(8982):1085-7. doi: 10.1016/s0140-6736(95)91748-9.
- Pan D, Patel AU, Patterson JM, Johnson AR, Gordon T, Mackinnon SE. Surgeons, physiatrists and neurologists speaking "EDX and nerve surgery": A paradigm shift for nerve injured patients. JPRAS Open. 2025 Nov 12;47:3-20. doi: 10.1016/j.jpra.2025.11.004. eCollection 2025.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2024-08365-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Reliability of Sensory Neurography and S2PD
-
Integra LifeSciences CorporationAcclarentCompletedEvaluate Performance and Reliability of Iontophoresis SystemUnited States
-
University of BolognaRecruitingRange of Motion, Articular | Reliability and Validity | Ankle JointItaly
-
Asir John SamuelCompletedThe Study Focuses to Find the Intrarater Reliability, Test-retest Reliability and Validity of 10 Meters Walk Test Among Middle School Going ChildrenIndia
-
Pamukkale UniversityCompletedMultiple Sclerosis | Proprioceptive Disorders | Reliability | Validity | Sensory ImpairmentsTurkey
-
Selcuk UniversityActive, not recruitingto Evaluate the Feasibility, Reliability, Validity, and Responsiveness of the QoR-15TTurkey
-
Gazi UniversityCompletedEvaluating the Validity and Reliability of the Turkish WOOSTurkey
-
Thammasat University HospitalCompletedValidity of Thai Version of the ICIQ-FLUTS LF Questionnaire | Reliability of Thai Version of the ICIQ-FLUTS LFThailand
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioNot yet recruitingPROMs | ACL Injury | Scale Reliability Validity | Validation and Cultural Adaptation of a ScaleItaly
-
Duke UniversityNational Institute of Allergy and Infectious Diseases (NIAID); The Miriam Hospital and other collaboratorsCompletedCharacterize Gel Distribution in the Vagina | Study Women's Sensory Perceptions and Preferences of GelUnited States
-
Amsterdam UMC, location VUmcRoyal Dutch VisioNot yet recruitingDual Sensory Impairment of Vision and HearingNetherlands